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As part of the ongoing research for more effective antimalarial drug, Fe (III) complex of mefloquine 
hydrochloride (antimalarial drug) was synthesized using template method. Mefloquine was tentatively 
found to have coordinated through the hydroxyl and the two nitrogen atoms in the quinoline and 
piperidine in the structure, respectively. Characterization has been done on the basis of analytical, 
conductance, atomic absorption, magnetic measurement, electronic and Infra-red spectrometry. From 
analytical data, the stoichiometry of the complex has been found to be 1:1. Infra-red spectral data also 
suggest that the ligand (mefloquine) behaves as a tridentate ligand with N:N:O donor sequence 
towards the metal ion. On the basis of the above physico-chemical data it is proposed that the complex 
is assigned octahedral geometry. The antimicrobial activities of mefloquine metal complex exhibited 
greater inhibition than the parent ligand. The ligand and metal complex were screened for their 
toxicological activities at the dose of 6.66 mg/kg body weight twice daily for seven days on the alkaline 
phosphatase (ALP), alanine aminotranferase (ALT) and aspartate aminotransferase (AST) activities of 
rat serum, liver and kidney. Overall, it was revealed that both mefloquine and its metal complex might 
show mild toxicity particularly on the liver and kidney.  
 




Malaria is a parasitic disease that has brought misery and 
death to many parts of the world. Despite the huge efforts 
being made to control the disease, malaria can be 
considered one of the worlds most wide spread deva-
stating disease causing illness and death in the world, 
particularly in Africa (WHO, 1981). 
Earlier hopes of eradicating malaria with drugs and 
insecticides in the late 1950s and early 1960s were 
dashed in 1966 by the development and spread of drug-
resistant malaria parasites and of insecticide-resistant 
mosquitoes carrying the parasites (Audu, 1991). In the 
last 30 years the emergence and increasing problem of 
drug resistance particularly to Plasmodium falciparum 
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Abbreviation: W, weak; B, broad; S, strong. 
rekindled research interest in the development of new 
and more effective drugs, natural or synthetic, with novel 
actions as well as a resurgence of interest in old drugs. 
Various studies have been carried out on complexation 
of some common antimalarial drugs with metals (Obaleye 
et al., 1997). The basic aim of the studies is to find mole-
cules that would be more effective therapeutic substitutes 
for available antimalarial drugs that the malaria parasites 
had developed resistance against (Obaleye et al., 1999). 
Mefloquine hydrochloride (ligand employed in this 
study) is (±)-erythro--(2-piperidyl)-2,8-bis(trifluoromethyl) 
-4-quinoline methanol, are known for their antimalarial 
activity. The choice of quinoline moiety was as a result of 
the success with the case of chloroquine. Mefloquine was 
the only candidate drug that came off successfully during 
Vietnam War. Its total synthesis was first reported by 
Ohnmacht et al. (1971). 
More than 10,000 synthesized compounds, most of 
which were based on the quinoline moiety, were screen-
ed for antimalarial activity during the Vietnam War at the 
Walter  Reed   Army   Institute  (WRAI)   in  U.S.A  (WHO,  
 




1987). Mefloquine is a white or slightly yellow, crystalline 
powder, very soluble in water, freely soluble in methanol 
and alcohol. It melts at about 260°C, with decomposition. 
Mefloquine shows polymorphism. Since the ligand 
(mefloquine) consists of potential binding sites such as 
oxygen and two nitrogen atoms, this work set out to study 
out the coordination tendencies, characterization after 








Metal salts iron(III) chloride hexahydrate used for the complexation 
was obtained from British Drug Houses chemical limited, Poole, 
England and were used as supplied. The ligand (mefloquine 
hydrochloride) was obtained from SWISS pharmaceuticals Com-
pany Lagos, Nigeria. ALP, ALT and AST assay kits were obtained 
from Randox Laboratories Limited., Antrim, United Kingdom. 
Isolates of Escherichia coli, Klebsiella pneumonia and Staphylo-
coccus aureus were obtained from the Department of Microbiology, 
University of Ilorin, Nigeria. Albino rats (Wistar strain) were obtained 
from the Department of Biochemistry, University of Ilorin, Nigeria. 
This study was carried out in the Department of Chemical Sciences 
Laboratory, Ajayi Crowther University, Oyo, Nigeria. 
 
 
Synthesis of the metal complex 
  
The complex was prepared based on previous reported procedures 
with slight modifications (Nadira and Singh, 1987; Ogunniran et al., 
2008). 0.01 mol of ethanolic solutions of Iron (III) chloride (FeCl3. 
6H2O) were prepared in a round bottomed flask. 0.01 mol (4.148 g) 
of Mefloquine Hydrochloride was dissolved in 20 ml ethanol and 
added to the solution of the metal salt in 10 ml ethanol in the round-
bottomed flask fitted with a condenser and refluxed with constant 
stirring for 2 h. The chelate was separated out after leaving it for 
four days. The metal chelates thus separated were filtered and 
washed with methanol and then with distilled water to remove 
unreacted ligand and metal. Finally the solid complex was dried in a 
dessicator. 10% methanolic ammonia solution was used to maintain 
the pH of the reacting solution of metal salt and ligand under reflux. 
 
 
Determination of physical properties of the complex 
 
Infra-red spectral of the ligand and complex were recorded in KBr 
disc in the range (4000 - 6000 cm-1) on PUC Scientific model 500 
FTIR Spectrometer. Electronic spectra were on Aquamate Spec-
trophotometer Model V4.60. The metal estimation was done using 
an Alpha4 Atomic Absorption Spectrophotometer with PM 8251 
simple-pen recorder. Conductivity measurements were carried out 
using WTW Conductometer Bridge. Thin layer Chromatography 
was carried out using TLC plate coated with silica gel. 
 
 
Antimicrobial screening of the ligand and metal complex 
 
The stimulatory or inhibitory activity of the ligand and the metal 
complex synthesized were determined according to the procedure 
previously reported by Obaleye and Famurewa (1989) as modified 
by Mohamed and Abdel-Wahab (2005). The bacteria species used 





coccus aureus and Klebsiella pneumonia. The antibacterial active-
ties of the compounds were estimated on the basis of the size of 
the inhibition zone formed around the wells on sensitivity media. 
Antifungal activity of each compound was determined using culture 
of three fungi species; they are Aspergillus niger, Aspergillus flavus 
and Rhizopus species. They were cultured on potato dextrose agar. 
The plates were incubated aerobically at 28 ±2°C for 96 h. 
 
 
Treatment of animals 
 
Male albino rats (Wistar strain), weighing between 160 - 180 g were 
obtained from the Department of Biochemistry, University of Ilorin, 
Ilorin and housed in the animal house of the Department of Chemi-
cal Sciences, Ajayi Crowther University, Oyo, Nigeria for acclimati-
zation. They were kept in wire meshed cages and fed with comer-
cial rat chow (Bendel Feeds Nigeria Ltd) and supplied water ad 
libitum. 
Eighteen rats were divided into three groups of 6 rats per group. 
The first group was used as control and received distilled water. 
The second group of rats was treated with free ligand (mefloquine), 
while the third group was treated with metal complex (Fe(Mef)Cl3). 
The distilled water, ligand and solution of metal complex were 
administered orally to the rats of various groups two times daily, 
morning and evening for seven days at the dose of 6.66 mg/kg 




Preparation of serum and tissue homogenates 
 
The method described by Yakubu et al. (2005) was used to prepare 
the serum. The rats were sacrificed by stunning. Blood samples 
were collected by cardiac punctures into clean, dry centrifuge tubes 
after which they were left for 10 min at room temperature. The 
tubes were then centrifuged for 10 min at 3000 x g in an MSC 
(Essex, UK) bench centrifuge. The clear supernatant (serum) was 
aspirated using a Pasteur pipette into clean, dry sample bottles and 
then frozen overnight before use.   
The liver and kidney excised from rat, blotted of blood stains 
were rinsed in 1.15% KCl and homogenized in 4 volumes of ice-
cold 0.01 M potassium phosphate buffer (pH 7.4). The homo-
genates were centrifuged at 12,500 x g for 15 min at 4°C and the 
supernatants, termed the post-mitochondrial fractions (PMF) were 
aliquoted and used for enzyme assays. 
 
 
Determination of serum and tissue ALP, AST and ALT 
activities 
 
Serum and tissue’s ALP, AST and ALT activities were determined 
using Randox diagnostic kits. Determination of AST and ALT 
activities were based on the principle described by Relitman and 
Frankel (1957). ALP activity determination was based on the 
method of Wright et al. (1972). The yellow coloured p-nitrophenol 
formed was monitored at 405 nm. Protein determination of serum 
and all fractions was estimated by the method of Lowry et al. (1951) 






The data were analyzed using one way ANOVA followed by Dun-
can multivariable post-hoc test for comparison between control and 
treated rats in all groups. P values less than 0.05 were considered 
statistically significant. 
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Colour Yield (%) 
Metal content (%) 
theoretical (experimental) 
Conductivity 
(-1 cm-1 dm-3) 
Mefloquine(Mef) 259 - 260 White - - 3.221 x 10-5 




Table 2. UU/Visible spectral assignment of mefloquine and its 
metal complex. 
 












RESULTS AND DISCUSSION 
 
The metal chloride salt possibly reacts with the ligand L 




. nH2O + L → ML 
. X3 + nH2O 
 
Where M = Fe3+ metal salt, L = Mefloquine and X = 
Chloride 
The complex synthesized was found to be a non-
hygroscopic solid with a light yellow colour (Table 1). The 
complex is very soluble in ethanol, methanol and distilled 
water. It has a sharp melting point and no decomposition 
observed. The average percentage yield was 66.2%. The 
retention factor (Rf) values were calculated from the 
developed single spot for the complex indicating the 
purity of the compound (Mohamed and Abdel-Wahab, 
2005). The Rf of the metal complex was found to be 
higher than the ligand. Comparing the conductivity of the 
ligand with that of the metal complex, at a room tempe-
rature suggests that it is non-electrolytic in nature. The 
analytical data of the antimalarial metal complex showed 
1:1 stoichiometry. 
The UV-spectra of the ligand and its metal complex 
have been interpreted in terms of charge transfer transi-
tions from the metal to the anti-bonding orbital of the 
ligand and of the π → π∗ transitions of the ligand (William 
et al., 1980). The ultraviolet spectrum of the free meflo-
quine HCl shows two absorption bands at 272.0 nm and 
207.0 nm (Table 2). These transitions involve energies of 
36765 and 48309 cm-1. The bands have been assigned 
to the n → π∗ and n → σ∗ transition, respectively. These 
bands undergo hypsochromic shifts in the metal complex 
due to complexation. The infrared data (Table 3) showed 
the results of most informative and indicative region.  The 






(cm-1) Tentative assignment 
3447.4 w,b 3341.9 b (OH), (N–H) stretch 
2925.1 s,b 2931.3 w,b (C–H) stretch of CH3 
1586.2 s 1520.8 s (C=N) 




assignments have been interpreted based on literature 
values obtained for similar structural compounds 
(Obaleye et al., 1999). The shifts observed in the absorp-
tion bands between mefloquine and its metal complex 
show that there is coordination. Metal-Ligand bands were 
observed in the ranges of 610-950 cm-1 in the metal 
complex. As shown in Table 4, the Fe(III) complex shows 
a µeff value of 6.00 BM, which corresponds to high spin 
(octahedral) stereo-chemistry (Kamaruddin and Roy,  
2001) 
Figures 1 and 2 show the results of antibacterial and 
antifungal activities of free mefloquine and metal com-
plexes. The studies of the ligand and its metal complex 
gave the antimicrobial activity of the compounds. The 
Metal complex was found to be more active at higher (1.0 
g/dm3) concentration than its corresponding ligand. The 
synthesized complex was active against the three 
bacteria used, while they were found to be active against 
only two of the fungi used, Aspergillus niger and 
Aspergillus flavus. Reports have shown that FeCl3.6H2O 
has no inhibitory activity on bacteria and fungi species 
(Obaleye et al., 1999). 
Figures 3-5 show the results of ALP, ALT and AST 
activities of the serum, kidney and liver. There was a 
significant reduction (p < 0.05) in serum ALP activities of 
mefloquine and its metal complex treated rats compared 
with the control. The observed significant increase in the 
ALP activities in the liver and kidney of the rats adminis-
tered with mefloquine and the metal complex suggests an 
enhancement of the activities of the existing enzymes by 
the drugs and their metabolites. The increase may be as 
a result of stress imposed on the tissue by the drug, 
which may lead to loss of the enzyme molecule through 
leakage into extra-cellular fluid.  ALP is a membrane-
bound enzyme often used to assess the integrity of the 
plasma membrane and endoplasmic reticulum (Akanji et 
al., 1993). In a bid to  offset  this  stress,  the  tissue  may  
 




























Figure 1. Inhibitory activity of the ligands and metal complexes against E. coli, S. aureus 






























Figure 2. Inhibitory activity of the ligands and metal complexes against A. niger, Rhizopus 




increase the de novo synthesis of the enzyme, thus 
accounting for the increase in ALP activities in these 
tissues (Malomo et al., 1993). The serum ALT activity in 
rats administered with mefloquine did not show significant 
difference compared with control. However, the meflo-
quine and its metal complex caused an increase in serum 
AST activity compared with control with a concomitant 
significant reduction in kidney AST activity. AST and ALT 
are enzymes associated with liver parenchymal cells. 
They are raised in acute liver damage. They are also 
present in red blood cells, heart cells, muscle tissue, pan-
creas and kidneys. When body tissue or an organ such 
as the heart or liver is diseased or damaged, additional 
AST and ALT are released into the bloodstream. Both 
ALT and AST levels are reliable indicators of liver dam-
age. In short, increase in serum ALT and AST has been 
reported in conditions involving necrosis of hepatocytes 
(Macfarlane et al., 2000), myocardial cells, erythrocyte 
and skeletal muscle cells (Halworth and Capps, 1993). 
Alteration in serum/tissue levels of ALP, AST and ALT as 
recorded in this studies are indications of derangement in 
cellular activities. 
 








































Figure 3. Effect of administration of ligands and metal complexes on the activities of alkaline phosphatase of rat 







































Figure 4. Effect of administration of ligands and metal complexes on the activities of alanine amino transferase (ALT) of 




Table 4. Magnetic moment of the ligands and metal complexes. 
 




% Metal content found 
(calculated) 
Mefloquine C17H16F6N20 414.80 - - 






The results of the  chemical  and  physical  analysis  from  
this study show that the ligand (mefloquine) employed in 
this work coordinated with Fe(III). The metal complex 
possesses   better   physical  properties  than  the  parent  
 





































    
Figure 5. Effect of administration of ligands and metal complexes on the activities of aspartate amino transferase (AST) 




compound. The toxicological studies revealed that both 
mefloquine and its metal complex might show mild 
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